Medifocus Announces Acceptance at Two Medical Society Meetings: Posters and Oral Presentations on Past Clinical Trial Results and the Upcoming Phase III Pivotal Study will be Given

COLUMBIA, Md.--(BUSINESS WIRE)--Medifocus Inc. (OTC:MDFZF.PK and TSXV:MFS) is pleased to announce that clinical presentations of the Company’s breast cancer treatment system, the Microfocus APA-1000, will be made at two medical society Annual Meetings in March and April 2010.

MORE ON THIS TOPIC